Trazodone updated on 07-01-2025

Congenital heart defects

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18172
R76411
Chan (Controls exposed to SSRIs), 2024 Cardiac malformations 1st trimester retrospective cohort (claims database) exposed to other treatment, sick excluded Adjustment: No Monotherapy: substance alone among all Antidep (SSRI, SNRI, ...) 0.55 [0.03;9.25] C
excluded (control group)
0/35   24/956 24 35
ref
S18153
R76310
Chan (Controls unexposed, pop general), 2024 Cardiac malformations 1st trimester retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: No Monotherapy: substance alone among all Antidep (SSRI, SNRI, ...) 0.81 [0.05;13.25] C 0/35   8,107/462,377 8,107 35
ref
Total 1 studies 0.81 [0.05;13.25] 8,107 35
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Chan (Controls unexposed, pop general), 2024Chan, 2024 1 0.81[0.05; 13.25]8,107350%ROB confusion: criticalROB selection: moderateROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate0.22.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, pop general;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 0.81[0.05; 13.25]8,10735 -NAChan (Controls unexposed, pop general), 2024 1 case control studiescase control studies 0 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 0.81[0.05; 13.25]8,10735 -NAChan (Controls unexposed, pop general), 2024 1 Tags Adjustment   - No  - No 0.81[0.05; 13.25]8,10735 -NAChan (Controls unexposed, pop general), 2024 1 Monotherapy   - substance alone among all Antidep ( ...  - substance alone among all Antidep (SSRI, SNRI, ...) 0.81[0.05; 13.25]8,10735 -NAChan (Controls unexposed, pop general), 2024 1 All studiesAll studies 0.81[0.05; 13.25]8,10735 -NAChan (Controls unexposed, pop general), 2024 10.210.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 18172

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 0.81[0.05; 13.25]8,10735 -NAChan (Controls unexposed, pop general), 2024 1 exposed to other treatment, sick controlsexposed to other treatment, sick controls 0.55[0.03; 9.25]2435 -NAChan (Controls exposed to SSRIs), 2024 10.510.01.0